Skip to main content
. 2020 Aug 27;8(2):e000881. doi: 10.1136/jitc-2020-000881

Table 1.

Demographic and clinicopathological characteristics according to stage II CRC POLE status in FUSCC cohort

Characteristic POLE EDMs POLE wild-type and POLE non-EDMs P value
Total 9 (3.1) 286 (96.9) --
Age (IQR) 46 (43–54) 62 (54–71) <0.001
Gender 0.162
 Female 2 (22.2) 131 (45.8)
 Male 7 (77.8) 155 (54.2)
Histological type 0.196
 Adenocarcinoma 6 (66.7) 238 (83.2)
 Mucinous adenocarcinoma 3 (33.3) 48 (16.8)
Pathological grade 0.372
 Well 0 (0) 18 (6.3)
 Moderate 5 (55.6) 200 (69.9)
 Poor 3 (33.3) 59 (20.6)
 Unknown 1 (11.1) 9 (3.2)
Location 0.003
 Right 6 (66.7) 66 (23.1)
 Left 3 (33.3) 220 (76.9)
pT stage 0.832
 T3 5 (55.6) 169 (59.1)
 T4 4 (44.4) 117 (40.9)
LNH 0.498
 <12 1 (11.1) 58 (20.3)
 ≥12 8 (88.9) 228 (79.7)
Lymphovascular invasion 0.003
 Negative 4 (44.4) 237 (82.9)
 Positive 5 (55.6) 49 (17.1)
Perineural invasion 0.264
 Negative 8 (88.9) 206 (72.0)
 Positive 1 (11.1) 80 (28.0)
Pretreatment CEA 0.541
 Negative 8 (88.9) 231 (80.8)
 Positive 1 (11.1) 55 (19.2)
Chemotherapy 0.663
 No 3 (33.3) 116 (40.6)
 Yes 6 (66.7) 170 (59.4)
MSI status 0.043
 MSS 6 (66.7) 254 (88.8)
 MSI-H 3 (33.3) 32 (11.2)
RAS 0.109
 Wild-type 2 (22.2) 141 (49.3)
 Mutation 7 (77.8) 145 (50.7)
BRAF 0.116
 Wild-type 7 (77.8) 264 (92.3)
 Mutation 2 (22.2) 22 (7.7)
PTEN <0.001
 Wild-type 3 (33.3) 265 (92.7)
 Mutation 6 (66.7) 21 (7.3)
PIK3CA <0.001
 Wild-type 1 (11.1) 227 (79.4)
 Mutation 8 (88.9) 59 (20.6)

CEA, carcinoembryonic antigen; CRC, colorectal cancer; EDM, exonuclease domain mutation; FUSCC, Fudan University Shanghai Cancer Center; LNH, lymph nodes harvested; MSI-H, microsatellite instability-high; MSS, microsatellite stabilization.